Terahertz demethylation for cancer therapy

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

Carcinogenesis involves DNA methylation which is a primary alteration in DNA in the development of cancer before genetic mutation. Because the abnormal DNA methylation is found in most cancer cells, the assessment of DNA methylation using terahertz radiation can be a novel optical method to detect and control cancer. The methylation has been directly observed by terahertz time-domain spectroscopy and this epigenetic chemical change could be manipulated to the state of demethylation using resonant terahertz radiation. Demethylation of cancer cells is a key issue in epigenetic cancer therapy and our results demonstrate the feasibility of the cancer treatment using optical technique.

Original languageEnglish
Title of host publicationTerahertz Emitters, Receivers, and Applications XV
EditorsManijeh Razeghi, Mona Jarrahi
PublisherSPIE
ISBN (Electronic)9781510679429
DOIs
StatePublished - 2024
EventTerahertz Emitters, Receivers, and Applications XV 2024 - San Diego, United States
Duration: 18 Aug 202419 Aug 2024

Publication series

NameProceedings of SPIE - The International Society for Optical Engineering
Volume13141
ISSN (Print)0277-786X
ISSN (Electronic)1996-756X

Conference

ConferenceTerahertz Emitters, Receivers, and Applications XV 2024
Country/TerritoryUnited States
CitySan Diego
Period18/08/2419/08/24

Keywords

  • cancer imaging
  • cancer therapy
  • DNA methylation
  • Terahertz radiation
  • terahertz spectroscopy

Fingerprint

Dive into the research topics of 'Terahertz demethylation for cancer therapy'. Together they form a unique fingerprint.

Cite this